Clinical Trials Logo
  1. Home
  2. Osteoporosis
  3. NCT02156960
  4. Details
NCT02156960 Clinical Trial

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

Osteoporosis Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02156960
Other study ID # Deno-PTH2365
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date May 2014
Est. completion date November 2022

Study information
Verified date October 2020
Source Shinshu University
Contact Yukio Nakamura, MD, PhD
Phone +81-263-37-2659
Email yxn14@aol.jp
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It has not been well known about the changes of bone metabolic markers, bone mineral density and other bone-related markers after teriparatide and/or denosumab treatment in Japanese osteoporotic patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date November 2022
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 120 Years
Eligibility Inclusion Criteria: - Osteoporotic patients Exclusion Criteria: - none

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Denosumab treatment in osteoporotic patients
To examine the effectiveness of denosumab in osteoporotic patients
• Teriparatide treatment in osteoporotic patients
To examine the effectiveness of teriparatide in osteoporotic patients
• Denosumab and teriparatide treatment in osteoporotic patients
To examine the effectiveness of denosumab and teriparatide in osteoporotic patients

Locations
Country Name City State
Japan Yukio Nakamura Matsumoto Nagano

Sponsors (1)
Lead Sponsor Collaborator
Shinshu University

Country where clinical trial is conducted

Japan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes of bone mineral density Bone mineral density will be examined every 4-6 months to evaluate the suitability of the drug. every 4-6 months
Secondary Changes of bone turnover markers Bone turnover markers will be examined every 3-6 months to evaluate the suitability of the drug. every 3-6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Completed NCT03822078 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Phase 1
Recruiting NCT05845021 - Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty N/A
Completed NCT00092066 - A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Phase 3
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04736693 - Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
Completed NCT02922478 - Role of Comorbidities in Chronic Heart Failure Study
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Recruiting NCT02635022 - Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
Active, not recruiting NCT02617303 - Prevention of Falls and Its Consequences in Elderly People N/A
Completed NCT02566655 - Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis Phase 1
Completed NCT03420716 - Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Completed NCT02559648 - Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis Phase 2
Not yet recruiting NCT01854086 - Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday N/A
Unknown status NCT01913834 - Nasally and sc Administered Teriparatide in Healthy Volunteers Phase 1
Completed NCT02003716 - DeFRA Questionnaire as an Anamnestic Form N/A
Completed NCT01401556 - C-STOP Fracture Trial N/A
Completed NCT01757340 - Calorie Restriction With Leucine Supplementation N/A
Completed NCT02143674 - Muscle Strengthening Exercises and Global Stretching in Elderly N/A